Research location
Rimini
Italy
Advertisement
Research activity in Rimini
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 102 trials and 105 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Rimini
102 linked trials · page 2 of 3Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)NCT02134015 · 2014-03-01 · 1 site observation
TERMINATED
TRial on the Endocrine Activity of Neoadjuvant DegarelixNCT02005887 · 2014-02-01 · 1 site observation
COMPLETED
Schedules of Nab-Paclitaxel in Metastatic Breast CancerNCT01746225 · 2013-04-01 · 1 site observation
COMPLETED
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic SettingNCT01808573 · 2013-03-29 · 1 site observation
COMPLETED
A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)NCT02000375 · 2013-03-01 · 1 site observation
TERMINATED
Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLCNCT01848613 · 2012-10-01 · 1 site observation
COMPLETED
The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialNCT03402048 · 2012-07-01 · 1 site observation
UNKNOWN
Iressa Re-Challenge in Advanced NSCLC EGFR M+ Patients Who Responded to Gefitinib USed as 1st Line or Previous TreatmentNCT01530334 · 2012-07-01 · 1 site observation
COMPLETED
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100NCT01605227 · 2012-07-01 · 1 site observation
COMPLETED
Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With InsulinNCT02082028 · 2012-06-27 · 1 site observation
COMPLETED
The BEACON Study (Breast Cancer Outcomes With NKTR-102)NCT01492101 · 2011-12-01 · 1 site observation
COMPLETED
Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene MutationsNCT01320397 · 2011-05-01 · 1 site observation
UNKNOWN
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerNCT01188187 · 2010-11-01 · 1 site observation
COMPLETED
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer PatientsNCT01885013 · 2010-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 DiabetesNCT01167881 · 2010-08-01 · 1 site observation
COMPLETED
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 DiabetesNCT01060059 · 2010-04-01 · 1 site observation
COMPLETED
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerNCT00988208 · 2009-11-11 · 1 site observation
COMPLETED
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung CancerNCT00850577 · 2009-06-01 · 1 site observation
TERMINATED
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common PracticeNCT01192711 · 2009-05-01 · 1 site observation
UNKNOWN
Phase I Combination Ixabepilone + CisplatinNCT00832117 · 2009-05-01 · 1 site observation
COMPLETED
Study of Immunotherapy to Treat Advanced Prostate CancerNCT00861614 · 2009-05-01 · 1 site observation
COMPLETED
Angiotensin-converting-enzyme (ACE) Inhibitors in HemodialysisNCT00985322 · 2009-05-01 · 1 site observation
COMPLETED
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINNCT00831909 · 2009-01-01 · 1 site observation
COMPLETED
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast CancerNCT00721409 · 2008-09-15 · 1 site observation
COMPLETED
Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention TrialNCT00700856 · 2008-09-01 · 1 site observation
UNKNOWN
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)NCT00751205 · 2008-08-01 · 1 site observation
COMPLETED
Trial Of CP-751, 871 And Erlotinib In Refractory Lung CancerNCT00673049 · 2008-05-01 · 1 site observation
TERMINATED
BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast CancerNCT00528567 · 2007-12-01 · 1 site observation
COMPLETED
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast CancerNCT00553410 · 2007-08-01 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast CancerNCT00393939 · 2007-02-01 · 1 site observation
COMPLETED
CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)NCT03352648 · 2007-01-01 · 1 site observation
UNKNOWN
TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerNCT00349219 · 2006-12-01 · 1 site observation
COMPLETED
E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesNCT00337103 · 2006-09-20 · 1 site observation
COMPLETED
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01 · 1 site observation
COMPLETED
Sublingual Immunotherapy In Alternaria-Induced RhinitisNCT01127035 · 2006-01-01 · 1 site observation
COMPLETED
Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerNCT00296010 · 2005-08-01 · 1 site observation
TERMINATED
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaNCT00095290 · 2004-09-01 · 1 site observation
COMPLETED
Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCNCT00234468 · 2004-01-01 · 1 site observation
TERMINATED
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03 · 1 site observation
COMPLETED
Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesNCT00604656 · 2003-05-05 · 1 site observation
COMPLETED
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV InfectionNCT00062660 · 2003-05-01 · 1 site observation
APPROVED_FOR_MARKETING
Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)NCT00144170 · 2003-02-01 · 1 site observation
COMPLETED
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF StudyNCT00403910 · 2002-09-01 · 1 site observation
COMPLETED
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-LamivudineNCT00013897 · 2001-02-01 · 1 site observation
COMPLETED
Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)NCT00028301 · 2001-02-01 · 1 site observation
COMPLETED
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast CancerNCT00022516 · 2000-11-01 · 1 site observation
COMPLETED
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous TreatmentNCT00004584 · 1999-12-01 · 1 site observation
COMPLETED
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung CancerNCT00002823 · 1995-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.